Check out the posters of the ECR 2018 EuroSafe Imaging exhibition!
Thank you to the record 89 submitters that participated in the EuroSafe Imaging poster exhibition at ECR 2018! The posters attracted almost 1,500 views during the congress, which represents another record for EuroSafe Imaging.
We encourage you to browse through the posters online in EPOS™, and would like to briefly present some of the submissions in this newsletter.
The three most viewed posters at ECR 2018 were:
ESI-0090 ESR referral guidelines working group
This poster details the work of the ESR's working group on imaging referral guidelines, a group of experts developing the guidelines used in the clinical decision support system ESR iGuide. The WG works with the American College of Radiology, developing and maintaining decision support guidelines based on the ACR Appropriateness Criteria. The poster details some of the differences between the American and European versions of the guidelines. The guidelines are now available to any individual user via the ESR iGuide web portal.
ESI-0008 Establishing a justification policy and process for imaging examinations using ionising radiation
Submitted by diagnostic centres from Hungary, the Netherlands and Greece, this poster lays out how the Affidea network implements the justification requirements in the Euratom Basic Safety Standards Directive (2013/59), which applies in all EU member states since February 6, 2018. The procedure to be implemented includes the evaluation of the appropriateness and urgency of the examination as well as justification of the exposure taking into account a variety of factors. The policy addresses the roles of the referrer, the practitioner and the operator and applies in all Affidea centres.
ESI-0089 ESR iGuide
The poster on ESR iGuide focuses on implementations of the system in Croatia and Sweden, and details the implementation process and results of the first ESR iGuide pilot projects in Europe. In Croatia, ESR iGuide was installed at four hospitals in a national project coordinated by the Ministry of Health. The system was first used in "silent mode" without appropriateness feedback. After CDS alerts were turned on, the appropriateness rate of referrals increased by up to four percent, while inappropriate referrals were reduced by up to three percent within two months. More significant improvements were achieved after the official end of the four month project, with one hospital reporting a 15 percent improvement in the appropriateness of referrals.
In Sweden, referring physicians had the option of exiting the CDS workflow at any point. While in a majority of cases users exited the CDS workflow before requesting an exam, results showed that non-CDS referrals were not appropriate in 10 percent of cases, while referrals done through ESR iGuide were inappropriate only one percent of the time.
The EuroSafe Imaging exhibition also included two industry submissions:
ESR-0003 Non-grid bedside chest imaging: Improving image quality and workflow using fractional multiscale image processing
Submitted by Agfa HealthCare, this poster deals with the significant rise in bedside imaging and the associated challenges for technologists, particularly with regards to reducing the amount of scatter radiation reaching the detector. One option is to subtract the scatter using software, such as Agfa HealthCare’s MUSICA3 Chest+. MUSICA automatically optimizes output images while maintaining image quality, which was confirmed through a clinical image study comparing phantom and clinical images from 25 patient cases from five hospitals in the USA, Germany, and Belgium.
ESI-0086 Real-time patient dose measurement in CT Scan: An innovative solution to improve radiation awareness
The Fibermetrix poster on the topic of dose measurement presented Fibermetrix' functional real-time dosimetre IVIscan™ for x-ray dosimetry as a solution for the dose reporting and recording requirements in the Euratom Basic Safety Standards Directive (2013/59). The purpose of this detector is to improve control of the patient-dose and medical staff awareness. The poster details two studies, first on validating IVIscan™, and second a clinical study comparing CTDI measured with IVIscan™ and displayed by CT from a different manufacturer. A further multicentre study is currently underway in France.
Browse through all ECR 2018 EPOS™ posters here: